Details
Stereochemistry | UNKNOWN |
Molecular Formula | C17H25NO3 |
Molecular Weight | 291.3853 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1CC(CC(C)(C)N1C)OC(=O)C(O)C2=CC=CC=C2
InChI
InChIKey=QSAVEGSLJISCDF-UHFFFAOYSA-N
InChI=1S/C17H25NO3/c1-12-10-14(11-17(2,3)18(12)4)21-16(20)15(19)13-8-6-5-7-9-13/h5-9,12,14-15,19H,10-11H2,1-4H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12625946
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12625946
Eucatropine is known as an anticholinergic agent, which acts as antagonist of muscarinic cholinergic receptors.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?D04116 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3703893
in cat: The effect on behavior of eight anticholinergic agents: atropine, scopolamine, trihexyphenidyl, biperiden, homatropine, eucatropine, hexocyclium and propantheline, injected into the cerebral ventricle (ICV) of the cat was investigated and compared
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
202-900-0
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
m1146
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | Merck Index | ||
|
4SPJ105W8E
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
100-91-4
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
CHEMBL1618660
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
3216
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
SUB07351MIG
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
1820
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
DTXSID1048465
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
100000082320
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
C166782
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY | |||
|
7534
Created by
admin on Fri Dec 15 18:05:34 GMT 2023 , Edited by admin on Fri Dec 15 18:05:34 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)